Leigh Brody
Directeur/Bestuurslid bij Bloomsbury Genetic Therapies Ltd.
Profiel
Leigh Brody is currently the Director at Bloomsbury Genetic Therapies Ltd.
and Investment Manager at Albion Capital Group LLP.
Brody holds a doctorate degree from Imperial College London and an undergraduate degree from Simmons University.
Actieve functies van Leigh Brody
| Bedrijven | Functie | Begin |
|---|---|---|
Albion Capital Group LLP
 Albion Capital Group LLP Investment ManagersFinance Albion Ventures LLP (Albion Ventures) is a venture capital firm founded in 1996. The firm is headquartered in London. | Private Equity Investor | 01-01-2021 |
Bloomsbury Genetic Therapies Ltd.
 Bloomsbury Genetic Therapies Ltd. BiotechnologyHealth Technology Bloomsbury Genetic Therapies Ltd. is a British biotechnology company that specializes in developing gene therapy technologies for neurological and metabolic diseases. The company is based in Cambridge, UK. Bloomsbury Genetic Therapies was founded in 2021 by Adrien Lemoine, who has been the CEO since 2021. | Directeur/Bestuurslid | 01-04-2022 |
Opleiding van Leigh Brody
| Simmons University | Undergraduate Degree |
| Imperial College London | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Albion Capital Group LLP
Albion Capital Group LLP Investment ManagersFinance Albion Ventures LLP (Albion Ventures) is a venture capital firm founded in 1996. The firm is headquartered in London. | Finance |
Bloomsbury Genetic Therapies Ltd.
Bloomsbury Genetic Therapies Ltd. BiotechnologyHealth Technology Bloomsbury Genetic Therapies Ltd. is a British biotechnology company that specializes in developing gene therapy technologies for neurological and metabolic diseases. The company is based in Cambridge, UK. Bloomsbury Genetic Therapies was founded in 2021 by Adrien Lemoine, who has been the CEO since 2021. | Health Technology |